Cognitive deficits following coronary artery bypass grafting: Prevalence, prognosis, and therapeutic strategies

CNS Spectrums

Volumn 9, Issue 10, 2004, Pages 763-772

  Raja, Pushpa V ^a   Blumenthal, James A ^b   Doraiswamy, P Murali ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DEXANABINOL; DONEPEZIL; DOPAMINE; GLUTAMIC ACID; GROWTH FACTOR; MEMANTINE; METHYLPHENIDATE; NICOTINIC AGENT; NOOTROPIC AGENT; PHOSPHODIESTERASE INHIBITOR; RIVASTIGMINE; STATIN;

ALZHEIMER DISEASE; AMNESIA; BRAIN EDEMA; CLINICAL TRIAL; COGNITIVE DEFECT; COMPARATIVE STUDY; CONCENTRATION LOSS; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; EDUCATION; GENETIC CODE; HEREDITY; HUMAN; HYPERTENSION; HYPERTHERMIA; MICROEMBOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OFF PUMP CORONARY SURGERY; PERFUSION; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROBLEM SOLVING; REVIEW; RISK FACTOR; SURGICAL INJURY; TEMPERATURE MEASUREMENT;

EID: 8144224406     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900022409     Document Type: Review

References (60)

1. Selnes OA, KcKhann GM. Coronary-artery bypass surgery and the brain. N Engl J Med. 2001;3444:451-452.
2. Fearn SJ, Pole R, Wesnes K, Faragher EB, Hooper TL, McCollum CN. Cerebral injury during cardiopulmonary bypass: emboli impair memory. J Thorac Cardiovasc Surg. 2001;121:1150-60.
3. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395-402
4. Newman MF, Grocott HP, Mathew JP, et al. Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke, 2001;32:2874-2881.
5. Lee JD, Lee SJ, Tsushima WT, et al. Benefits of off-pump bypass on neurological and clinical morbidity: a prospective randomized trial. Ann Thorac Surg. 2003;76:18-26.
6. Immer FF, Berdat PA, Immer-Bansi AS, et al. Benefit to quality of life after off-pump versus on-pump coronary bypass surgery. Ann Thorac Surg. 2003;76:27-31.
7. McKhann GM, Borowicz LM, Goldsborough MA, Enger C, Selnes OA. Depression and cognitive decline after coronary artery bypass surgery. Lancet. 1997;349:1282-1284.
8. Selnes OA, Royall RM, Grega MA, Borowicz LM, Quaskey S, McKhann GM. Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline? Arch Neurol. 2001;58:598-604.
9. Mullges W, Babin-Ebell J, Reents W, Toyka KV. Cognitive performance after coronary artery bypass grafting: a follow-up study. Neurology. 2002;59:741-743.
10. Keith JR, Puente AE, Malcolmson KL, Tartt S, Coleman AE, Marks HF. Assessing postoperative cognitive change after cardiopulmonary bypass surgery. Neuropsychology. 2002;16:411-421.
11. Haddock CK, Poston WS, Taylor JE. Neurocognitive sequelae following coronary artery bypass graft: a research agenda for behavioral scientists. Behav Modif. 2003;27:68-82.
12. Borger MA, Green RE, Weisel RD. Defining neuropsychological impairment: should we abandon the "20% of tests" rule? Ann Thorac Surg. 2002;73:S369.
13. Keith JR, Puente AE. Deficiencies in the detection of cognitive deficits. Neuropsychology. 2002;16:434-439.
14. Mahanna EP, Blumenthal JA, White WD, et al. Defining neuropsychological dysfunction after coronary artery bypass grafting. Ann Thorac Surg. 1996;61:1342-1347.
15. Kneebone AC, Andrew MJ, Baker RA, Knight JL. Neuropsychologic changes after coronary artery bypass grafting: use of reliable change indices. Ann Thorac Surg. 1998;65:1320-1325.
16. Selnes OA, Grega MA, Borowicz LM, Royall RM, McKhann GM, Baumgartner WA. Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls. Ann Thorac Surg. 2003;75:1377-1386.
17. Hlatky MA, Bacon C, Boothroyd D, et al. Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery. Circulation. 1997;96(9 suppl):II-11-4; discussion 11-15.
18. Canet J, Raeder J, Rasmussen LS, et al. Cognitive dysfunction after minor surgery in the elderly. Acta Anaesthesiol Scand. 2003;47:1204-1210.
19. Grichnik KP, Ijsselmuiden AJ, D'Amico TA, et al. Cognitive decline after major noncardiac operations: a preliminary prospective study. Ann Thorac Surg. 1999;68:1786-1791.
20. Galanakis P, Bickel H, Gradinger R, Von Gumppenberg S, Forstl H. Acute confusional state in the elderly following hip surgery: incidence, risk factors and complications. Int Journal of Geriatric Psychiatry. 2001;16:349-355
21. Abildstrom H, Rasmussen LS, Rentowl P, et al. Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiol Scand. 2000;44:1246-1251
22. Williams-Russo P. Sharrock NE. Mattis S. Szatrowski TP. Charlson ME. Cognitive effects after epidural vs general anesthesia in older adults. A randomized trial. JAMA. 1995;274:44-50.
23. Selnes OA, McKhann GM. Late cognitive decline after CABG: inevitable or preventable? Neurology. 2002;59:660-661.
24. Murkin JM, Newman SP, Stump DA, Blumenthal JA. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg. 1995;59:1289-1295.
25. Blumenthal JA, Mahanna EP, Madden DJ, White WD, Croughwell ND, Newman MF. Methodological issues in the assessment of neuropsychologic function after cardiac surgery. Ann Thorac Surg. 1995;59:1345-1350.
26. Newman S, Klinger L, Venn G, Smith P, Harrison M, Treasure T. Subjective reports of cognition in relation to assessed cognitive performance following coronary artery bypass surgery. J Psychosom Res. 1989;33:227-233.
27. Khatri P, Babyak M, Clancy C, et al. Perception of cognitive function in older adults following coronary artery bypass surgery. Health Psychol. 1999;18:301-306.
28. Selnes OA, Goldsborough MA, Borowicz LM, Enger C, Quaskey SA, McKhann GM. Determinants of cognitive change after coronary artery bypass surgery: a multifactorial problem. Ann Thorac Surg. 1999;67:1669-1676.
29. Van Dijk D, Jansen EW, Hijman R, et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. JAMA. 2002;287:1405-1412.
30. Taggart DP, Browne SM, Halligan PW, Wade DT. Is cardiopulmonary bypass still the cause of cognitive dysfunction after cardiac operations? Ann Thorac Cardiovasc Surg. 1999;118:414-421.
31. Van Dijk D, Jansen EW, Hijman R, et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery. JAMA. 2002;287:1405-1412.
32. Keizer AM, Hijman R, van Dijk D, Kalkman CJ, Kahn RS. Cognitive self-assessment one year after on-pump and off-pump coronary artery bypass grafting. Ann Thorac Surg. 2003;75:835-839.
33. Grigore AM, Grocott HP, Mathew JP, et al. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg. 2002;94:4-10.
34. Rodig G, Rak A, Kasprzak P, Hobbhahn J. Evaluation of self-reported failures in cognitive function after cardiac and noncardiac surgery. Anaesthesia. 1999;54:826-830
35. Engleman RM, Pleet AB, Rousou JA, Flack JE, Deaton DW, Pekow PS, Gregory CA. Influence of cardiopulmonary bypass perfusion temperature on neurologic and hematologic function after coronary artery bypass grafting. Ann Thorac Surg. 1999;67:1547-1556.
36. Khatri P, Babyak M, Croughwell ND, et al. Temperature during coronary artery bypass surgery affects quality of life. Ann Thorac Surg. 2001;71:110-116.
37. Grocott HP, Mackensen GB, Grigore AM, et al. Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. Stroke. 2002;33:537-541.
38. Newman MF, Croughwell ND, Blumenthal JA, et al. Predictors of cognitive decline after cardiac operation. Ann Thorac Surg. 1995;59:1326-1330.
39. Selnes OA, Goldsborough MA, Borowicz LM, McKhann GM. Neurobehavioral sequelae of cardiopulmonary bypass. Lancet. 1999;353:1601-1606.
40. Tardiff BE, Newman MF, Saunders AM, et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. Ann Thorac Surg. 1997;64:715-720.
41. Steed L, Kong R, Stygall J, et al. The role of apolipoprotein E in cognitive decline after cardiac operation. Ann Thorac Surg. 2001;71:823-826.
42. Ti LK, Mathew JP, Mackensen B, et al. Effect of apolipoprotein E genotype on cerebral autoregulation during cardiopulmonary bypass. Stroke. 2001;32:1514-1519.
43. Alston RP, Millar SM. Neurological outcome and S100 after coronary artery bypass grafting and abdominal aortic surgery. Ann Thorac Surg. 2002;73:S368
44. Westaby S, Johnsson P, Parry AJ, et al. Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg. 1996;61:88-92.
45. Snyder-Ramos SA, Gruhlke T, Bauer H, et al. Cerebral and extracerebral release of protein S100B in cardiac surgical patients. Anaesthesia. 2004;59:344-349.
46. Caplan L. Protecting the brains of patients after heart surgery. Arch Neurol. 2001;58:549-550.
47. Kohn A. Magnetic resonance imaging registration and quantitation of the brain before and after coronary artery bypass graft surgery. Ann Thorac Surg. 2002;73:S363-S365.
48. Uebelhack R, Vohs K, Zytowsti M, et al. Effect of piracetam on cognitive performance in patients undergoing bypass surgery. Pharmacopsychiatry. 2003;36:89-93.
49. Wang D, Wu X, Li J, Xiao F, Liu X, Meng M. The effect of lidocaine on early postoperative cognitive dysfunction after coronary artery bypass surgery. Anesth Analg. 2002;95:1134-1141.
50. Mitchell SJ, Pellett O, Gorman DF. Cerebral protection by lidocaine during cardiac operations. Ann Thorac Surg. 1999;67:1117-1124.
51. Butterworth, J. Invited Commentary on "Cerebral protection by lidocaine during cardiac operations" (Mitchell et al.) Ann Thorac Surg. 1999;67:1124.
52. Thaminy S, Reymann JM, Heresbach N, Allain H, Lechat P, Bentue-Ferrer D. Is chlomethiazole neuroprotective in experimental global cerebral ischemia? A microdialysis and behavioral study. Pharmacol Biochem Behav. 1997;56:737-745.
53. Smith DH, Perri BR, Raghupathi R, Saatman KE, McIntosh TK. Remacemide reduces cortical lesion volume following brain trauma in rats. Neurosci Lett. 1997;231:135-138.
54. Pharmos Corporation Web site. Available at: http://www.pharmoscorp.com. Accessed on July 28, 2004.
55. Amory DW, Grigore A, Amory JK, et al. Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients. J Cardiothorac Vasc Anesth. 2002;16:270-277.
56. Doraiswamy PM. Noncholinergic therapies for treating and preventing Alzheimer's disease. CNS Drugs. 2002;16:811-824.
57. Doraiswamy PM. Interventions for mild cognitive impairment and Alzheimer's disease: new strategies, new hopes. Am J Geriatr Psychiatry. 2003;11:120-122.
58. Doraiswamy PM, Chen G, Charles HC. Brain 1H-MR Spectroscopy: role in assessing Alzheimer's disease outcomes. CNS Drugs. 2001;14:457-472.
59. Bendszus M, Reents W, Franke D, et al. Brain damage after coronary artery bypass grafting. Arch Neurol. 2002;59:1090-1095.
60. Ravdin LD, Mattis PJ, Lachs MS. Assessment of cognition in primary care: neuropsychological evaluation of the geriatric patient. Geriatrics. 2004;59:37-44.